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The Shoulder Disability Questionnaire (SDQ) is a measure covering 16 items designed to evaluate functional status limitation in pa-
tients with shoulder disorders.The responsiveness of the SDQ was evaluated for 180 patients with soft tissue shoulder disorders, without
underlying systemic disorders. These patients participated in a randomized placebo-controlled trial, in which ultrasound and electrother-
apy appeared to be ineffective as adjuvants to standardized exercise therapy. At baseline and at 6-week follow-up, patients completed the
SDQ and rated severity of shoulder pain and their chief complaint, while a research physiotherapist rated severity of symptoms and re-
striction of mobility. At the 6-week follow-up, patients also rated overall change since baseline. According to the calibrated responsive-
ness ratio (CRR) and the area under the receiver-operator characteristic curve (AUC) the SDQ discriminates accurately between self-
rated clinically stable and improved subjects. The presented results suggest that the SDQ is as responsive as the compared outcome mea-








Shoulder disorders may limit functional status, impairing
the ability of patients to perform functional activities in
daily life in a normal manner. Improvement of functional
status is an important goal in the treatment of patients with
shoulder disorders, and may reduce restriction of socially
defined tasks and roles. Therefore, functional status mea-
sures are essential in the evaluation of treatment outcome.
Yet, in clinical trials on shoulder disorders, little attention is
given to functional status measurement [1–3]. In our opin-
ion, it is fundamental that functional status measures are
brief, take a short time to complete, and allow self-as-
sessment and completion by patients. Besides covering all
crucial elements of functional status, the components of
functional status measures must focus on the actual execu-
tion of activities that are important in daily life, rather than
on the desire to perform them or the perceived possibility to
perform them. In addition, functional status measures must
be responsive. This means that they must be able to detect
clinically relevant changes—changes which are not due to
measurement error and biological variability. A summary
score should facilitate statistical processing and simple, di-
rect interpretation [4].
Most of the available assessment instruments for shoul-
der disorders are described in comprehensive reviews [5–7].
These instruments focus predominantly on assessment of
symptoms—such as pain, restricted mobility, and decreased
muscle power—that are considered to be correlates of func-
tional status limitation. When an evaluation of functional
status limitation is included, it typically addresses the clini-
cian’s appraisal of the possibility to perform daily activities,
instead of the patient’s self-report of their actual execution.
Most of the available instruments are developed in relation
to specific interventions for specific conditions, and little is
known about their applicability and responsiveness in other
situations.
This paper describes the design of the Shoulder Disabil-
ity Questionnaire (SDQ), a measure developed to evaluate
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functional status limitation through self-assessment by pa-
tients with soft tissue shoulder disorders who participate in
a randomized placebo-controlled trial on ultrasound and
electrotherapy as adjuvants to exercise therapy. Since many
outcome measures in our clinical trial were already patient-
preferred measures, we wanted to include a measure that
was preferred by the physical therapists. Almost simulta-
neously with the SDQ, several functional status question-
naires for shoulder disorders [8–10] have been developed,
which all appear to focus on the patient’s perspective for
evaluation of functional status limitation due to shoulder
disorders.
This paper also documents the responsiveness of the
SDQ on the basis of secondary analysis of data from this
trial, in which treatments turned out to be ineffective for soft






A pool of 60 candidate items was selected from routine
history of patients with shoulder disorders in physiotherapy
and by reviewing various functional status measures. Suit-
able items had to refer to activities in daily life involving the
upper extremities. In order to focus items on the shoulder,
we attached a subclause to each item that explicitly referred
to the shoulder. Items were phrased so that they addressed
the actual execution of a particular activity, rather than fo-
cusing on the desire to perform it or the perceived possibil-
ity to perform it. Items which included positive, negative, or
ambiguous expressions were rephrased neutrally. Likewise,
items with limited applicability were rephrased in more
general wording. For example, “
 
My shoulder hurts when I
put a wallet in my back pocket”
 
 was rephrased as 
 
“My













We aimed at a questionnaire of approximately 15 items,
and decided to reduce the number of items via two surveys.
Item reduction surveys were aimed at maximizing the valid-
ity of the SDQ according to the judgmental approach, as de-
scribed by Guyatt and co-workers [4,12]. Since many out-
come measures in our clinical trial already corresponded
with goals of patients, we wanted to include a patient-com-
pleted outcome measure that corresponded with treatment
goals of physical therapists.
Therefore, we mailed the list of 60 candidate items to
273 seasoned physiotherapists working in private primary
care practices in the south of the Netherlands and to 47 re-
searchers who had published papers on shoulder disorders
in Dutch (para)medical journals in 1990–1991. The address-
ees were asked to select 15 items concerning functional sta-
tus limitation mentioned most frequently by patients with
shoulder disorders. Participants were asked to focus on
symptoms and complaints, rather than on attribution of
symptoms to an underlying disorder. Next, they had to esti-
mate the impact of each selected item on functional status
(Likert scale: 1–5; not at all limiting to extremely limiting).
Participants were encouraged to comment on the list of
items and to add any items that they felt had been left out.
The response to this mailing was 56% for physiotherapists
and 60% for researchers. Items were ranked according to
the weight-frequency product that was calculated from the
returned questionnaires by multiplying the endorsement
frequency with the mean item score. We excluded items
with a frequency-weight product lower than the median





The ranking of the remaining 30 items revealed only mi-
nor differences between the 2 groups of respondents.
Guided by comments, unclear or confusing items were re-
phrased. During the second postal survey, the 273 physio-
therapists and 47 researchers were asked to select, out of
these 30 items, the 15 that they considered most crucial in
the evaluation of treatment outcome. Next, participants had
to estimate the sensitivity to change of each selected item of
functional status limitation (Likert scale: 1–5; not at all sen-
sitive to change to extremely sensitive to change). Again,
the respondents were encouraged to comment on the list of
items and to add any items that they felt had been left out.
The response rate for this mailing was 55% for physiothera-
pists and 72% for researchers. Items were ranked according
to the weight-frequency product calculated from the re-
turned questionnaires through multiplication of the endorse-
ment frequency by the mean sensitivity to change. The me-
dian frequency-weight product was approximately 300




 2.5). Since the frequency-
weight products of items14–20 were very close to the me-
dian, the draft SDQ consisted of 20 items. The two groups
of respondents showed virtually no differences in the rank-
ing of items. The majority of these 20 items were activities
that involved pushing, pulling, reaching, leaning or carrying.
 
2.3. Finalization for clinical use
 





the patient was restricted with respect to the particular activ-
ity. To improve accuracy, the recall period in the patient in-





 (NA) was added to focus patients on
the actual execution of activities, rather than on the desire or
the perceived possibility to perform them. A NA response
meant that the activity of the particular item (e.g., carrying
something) had not been performed in the previous 24
hours. The ratio of the number of items with an affirmative
answer over the number of applicable items was multiplied
by 100. This ratio was used as summary score and ranged
from a maximum of 100 (i.e., affirmative answer to all ap-
plicable items) to 0 (no functional status limitation).
 




In order to evaluate the applicability of the items and the
appropriateness of the answer option, 12 patients with
shoulder disorders treated by physical therapist completed
the draft SDQ. They were asked to comment on the format
and item wording, and add any items that they felt were
missing. Their comments resulted in refinements in the
wording of five items. Eight items addressing similar upper
extremity activities were combined: writing and typing,
opening and closing a door, gripping a steering wheel or
bike handlebars, and putting on a coat or a sweater. A pre-







The responsiveness of the SDQ was evaluated in 180 pa-
tients. Between 1 May 1992 and 1 November 1994 these pa-
tients were enrolled in a randomized placebo-controlled
trial for patients with soft tissue shoulder disorders in which
ultrasound (US) and electrotherapy (ET) had been ineffec-
tive [11]. Eligible patients had either or both (1) pain in the
deltoid region during glenohumeral movement, and (2) re-
stricted passive range of glenohumeral motion, while it was
very likely that they had either or both (3) a localized soft
tissue lesion, and (4) involvement of the sympathetic nerve
system. Excluded were patients who had a stroke, polyneur-
opathy, multiple sclerosis, rheumatoid arthritis, polymyal-
gia, ankylosing spondylitis, malignancy, hemophilia, prior
fractures, or prior surgery, along with those having motor or
sensory deficits, or wounds or skin defects in the shoulder,
upper limb, neck, or thorax. Furthermore, patients who were
considered to have major shoulder hypermobility, complete
rotator cuff tears, glenohumeral joint inflammation, or re-
ferred pain from the neck or from internal organs in the
shoulder were excluded, as well as those who had already
received ET or US during the current episode, were com-
pletely or nearly completely free of symptoms, or those who
indicated reluctance to adhere to the allocated treatment or
to complete follow-up.
Additionally, to increase the efficiency of the clinical
trial, patients at the positive end of the prognostic spectrum
were excluded because it was unlikely that ET and US
could hasten their recovery. These were patients with very
large improvement, who at the same time fulfilled three or
four of the following putative indicators of a favorable
prognosis: (1) only dominant side impaired, (2) first episode
ever, (3) no pain radiating below the elbow, or (4) no co-ex-
istent cervical or elbow disorder. For the same reason, pa-
tients at the negative end of the prognostic spectrum were
excluded because it was unlikely that they would benefit
from any treatment. These were patients without any im-
provement, who at the same time fulfilled three or four of
the following putative indicators of a poor prognosis: (1)
non-dominant side or bilateral impaired, (2) prior episodes,
(3) pain radiating below the elbow, or (4) co-existent cervi-
cal or elbow disorder. All consenting patients received exer-
cise therapy, while according to randomization, some pa-
tients received adjuvant physical modalities for only one
shoulder. In subjects with bilateral shoulder problems, the




In addition to completion of the SDQ at the end of the
qualification period and 6 weeks later, patients gave visual
analogue scale (VAS) severity ratings for (1) the chief com-
plaint in the preceding week, and (2) shoulder pain in the
preceding week. Simultaneously, based on a standardized
clinical assessment, the research physiotherapist gave VAS
severity ratings for (3) symptoms, and (4) mobility restric-
tion. The legend of Table 1 provides a more detailed de-
scription of these measures. All ratings ranged from 0 (min-
imum) to 100 (maximum). At 6 weeks, patients rated
overall change since baseline on an 8-point Likert transi-
tional scale. This rating was used as an external criterion for
the analysis of responsiveness. Complete recovery, very









; while much and very much worse was re-




 Data were analyzed with
SPSS for Windows (version 6.1.2).
 
3.3. Ability to detect change
 
We evaluated the individual SDQ items for those capable
of detecting change. For this purpose we plotted for each
item the distribution of change in answer options since
baseline, either improvement or deterioration, for all 180
patients. We also explored potential floor and ceiling effects
(i.e. the inability of an outcome measure to detect change
towards the end of its scale) given the room for change [13].
The presence of a floor effect was studied in subjects with
the lower quartile or the best SDQ baseline summary scores,
by calculating the proportion of clinically improved sub-
jects with an improvement in SDQ score since baseline. The
presence of a ceiling effect was studied in subjects with the
upper quartile or the worst SDQ baseline summary scores,
by calculating the proportion of clinically deteriorated sub-
jects with a deterioration in SDQ score since baseline.
The ability to detect any change of an outcome measure
can be assessed by an effect size statistic (ES) [14–20]. For
this, no external criterion is needed. In a single group de-
sign, the mean change in score in the population is used as
the numerator of the ES, while its denominator is expressed
as the associated standard deviation [14–18] or the standard
deviation of the baseline score [17]. In a control group de-
sign, the difference in mean change scores of the groups is
used as the numerator of the ES, while its denominator can
be expressed as the (pooled) standard deviation of the base-
line scores of the population [14–18]; the standard deviation
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deviation of the baseline scores of control group [17]. So far
no method for calculating ES has become a standard, since
none seems to be superior over the other. In general, the use
of a standard deviation of baseline scores in the denomina-
tor is expected to result in a larger ES, because it does not
include response variance.
Because an external criterion for clinically relevant
change was available in our study, we could assess the abil-
ity to detect clinically relevant change by a Responsiveness
Index (RI) [14,18–20]. Its numerator could be expressed as
the mean change in score of clinically changed subjects, the
mean change in score of subjects receiving a treatment of
known benefit, or the minimal clinically relevant difference
[18,19]. Its denominator could be expressed as the standard
deviation of change in subjects who are clinically stable, re-
ceive no treatment at all, or receive a placebo treatment
[18,19]. Again, no RI has become a standard, since none




We defined responsiveness as the ability of an instru-
ment to discriminate between clinically stable and improved
subjects. Responsiveness is, above all, a function of the
variability in clinically stable subjects [19,20]. In the ab-
sence of a gold standard for clinical stability, we consider
the average change in score since baseline in self-rated clin-
ically stable subjects to be the best estimate of the true value
for stability. We explored the responsiveness of the SDQ
and other outcome measures by their distribution of change
in score since baseline in self-rated clinically stable and im-
proved subjects (Fig. 1). The smaller the range of these dis-
tributions and the smaller their overlap, the larger the re-
sponsiveness of an outcome measure will be. Because all
outcome measures were used simultaneously in the same
study population, we evaluated and compared their respon-
siveness by two parameters: the calibrated responsiveness





We consider the ratio of the mean change in score of
clinically changed subjects and the standard deviation of
change in clinically stable subjects the most suitable RI for
our purpose. We calculated non-parametric CRRs with me-
dians and interquartile ranges (IQRs), because the change in
score since baseline of clinically stable and improved sub-
jects for the compared outcome measures had non-Gaussian
distributions (Fig. 1). Comparison of responsiveness of dif-
ferent outcome measures by this RI, however, may be com-
plicated by systematic changes in score since baseline in
clinically stable subjects. We wanted to calibrate the RI of
outcome measures for these changes. Therefore, analogous
to the numerator of the ES for a control group design, we
subtracted the median change score in clinically stable sub-
jects from the median change score in clinically improved
subjects. We denote the resulting ratio as CRR: the differ-
 
Table 1.













































Females (%) 51 49 52
Previous episodes (%)
None 56 44 65




2 18 26 9
Co-existent disorders (%)
Cervical 86 85 86
Homolateral elbow 68 70 66
Impaired shoulder (%)
dominant 50 50 51
right 59 56 62
Duration prior to intake (%)
0 weeks–3 months 38 35 42
3 months–6 months 27 30 22




12 months 16 18 15
Radiating pain below elbow (%) 73 67 76
Cause current episode (%)
Trauma 12 26 39
Unknown 52 56 48
Onset current episode (%)
Acute 32 26 39
Gradual 68 74 61
Symptoms prior to intake (%)
Stable 10 5 14
Increased 71 72 68














































Prognostic grading by the research physiotherapist on a visual ana-
logue scale (VAS; 0/100: best/worst), is based on symptom severity com-
bined with presented clinical characteristics. Rating of symptom severity
(VAS; 0/100: best/worst) was based on a standardized assessment, includ-
ing history; inspection of contour, muscle wasting, and swelling; active and
passive evaluation of range of motion and shoulder pain on abduction,
flexion, internal and external rotation, extension, and adduction; evaluation
of the mobility and active glenohumeral-scapulo-thoracic rhythm; evalua-
tion of joint play and shoulder pain on accessory movements; evaluation of
muscle weakness and shoulder pain on isometric muscle testing; and palpa-








Severity rating by the patient for the shoulder pain during the preced-




Severity rating by the patient for the chief complaint during the pre-
ceding week (VAS; 0/100: best/worst). The chief complaint was defined as





Severity rating for restriction of active mobility by research physio-
therapist (VAS; 0/100: best/worst), based on a standardized assessment of
(1) glenohumeral-scapulo-thoracic rhythm; reaching with the index finger
towards (2) the heterolaterol scapular angulus inferior and (3) the second
thoracic processus spinosus; (4) flexion; and (5) abduction.
 




ence between the median change in score since baseline for
self-rated clinically improved and stable subjects, over the
IQR of this change in clinically stable subjects. There is no
uniform threshold for the CRR above which an outcome
measure can be called responsive. The larger the CRR, the
larger the responsiveness of the outcome measure. If an out-
come measure has a CRR smaller than 1, the change in
scores since baseline of improved minus stable subjects
does not exceed the IQR (i.e., all possible variance) in stable
subjects, and we consider the outcome measure not respon-
sive.
Conceptually, the CRR is very similar to a Responsive-
ness Index (RI). The RI, as proposed by Guyatt, can be used
to compare the responsiveness of different outcome mea-
sures. The assumption underlying the validity of such a
comparison is that the mean changes in clinically stable
subjects are equal across the compared instruments. Ideally,
the mean changes in clinically stable subjects are equal to
zero. For several reasons, for example, regression to the
mean, these mean changes are neither similar across com-
pared instruments nor equal to zero. Therefore, the compar-
ison of instruments according to their RI is likely to yield
biased results. To adjust for this potential bias, we cali-
brated the RI by subtracting the mean change in clinically
stable subjects from the numerator for each instrument. Be-
cause the data for the compared instruments have a non-
Gaussian distribution, parametric statistics will result in bi-
ased CRRs. Therefore, we followed the suggestion of Kazis
[17] to use non-parametric statistics for the calculation of
effect sizes. When data have a Gaussian distribution, CRR




In the context of responsiveness, the ROC curve plots the
true-positive proportion (Y-axis) against the false-positive
proportion (X-axis) [20,21] of clinically improved subjects
with a change in score since baseline equal to or larger than
a cut-off point in the score range. The AUC for changes
since baseline represents the probability of correct discrimi-
nation between pairs of self-rated clinically stable and im-
proved subjects [20,21]. For the construction of the ROC
curves, we used steps of 10 points change in score since









100 points). There is
no uniform threshold for the AUC above which an outcome
measure is responsive. However, if the AUC is equal to 0.5




line of identity throughout the score range), it means that the
outcome measure does not discriminate between clinically
stable and improved subjects. This indicates that the out-
come measure is not responsive. The AUC approaches 1.0
if the ROC curve reaches higher and towards the left in the
diagram, indicating that the outcome measure approaches
perfect accuracy in discriminating between pairs of clini-
cally stable and improved subjects [20,21]. Under the as-
sumption of equal utility of true and false positive, the point
most upper left in the diagram represents the best cut-off
point, that is, the point with the optimal tradeoff between
true and false positive proportion or the highest likelihood
for correct discrimination of stable and improved subjects
[20,21]. The use of such a cut-off point may facilitate de-
cisions concerning treatment of patients with shoulder dis-
orders.
Fig. 1. Box plot for changes in score since baseline of compared outcome measures for stable subjects (n 5 82) and improved subjects (n 5 92). Boxes repre-
sent the range between 25th and 75th percentiles for the change in score since baseline. Horizontal lines inside boxes represent median change in score since








4.1. Subjects and responses
 
Table 1 presents the clinical characteristics of the 180
subjects, of whom 92 (51%) were clinically improved and
82 (46%) were clinically stable. All subjects could easily
complete the SDQ at baseline and 6 weeks later; completion
took between 5–10 minutes. At baseline and 6 weeks later,









 1–4). In addition, NA answers were most fre-
quently reported for items 7, 8, 11, and 16. Very few sub-
jects gave an affirmative answer at baseline for items 7 and









 6 weeks later or vice versa, was most fre-
quently reported for items 1, 2, 4, 6, and 12–14, while the
least change was reported for items 7, 10, and 16 (Fig. 2).
Hence, items 7 and 16 yield very little information about
change in functional status limitation.
 
4.2. Floor and ceiling effects
 
Of the 59 subjects with the best (or lower quartile) SDQ
baseline scores (0–63), the change in SDQ scores since
baseline exceeded zero in 25 (71%) of the 35 clinically im-
proved subjects and in 8 (33%) of the 24 non-improved sub-
jects. This suggests that the SDQ is also able to distinguish
between improved and non-improved subjects when there is
relatively little room for improvement of functional status at
baseline. Therefore, an important floor effect for the SDQ
summary score appears to be unlikely in our study popula-
tion. Of the 40 subjects with the worst (or upper quartile)
SDQ baseline scores (87–100), the SDQ scores since base-
line deteriorated in none of the 6 clinically deteriorated sub-
jects (0%) and in 2 of the 34 non-deteriorated subjects (6%).
This suggests that the SDQ is not able to distinguish be-
tween deteriorated and non-deteriorated subjects when there
is relatively little room for deterioration in functional status at
baseline. Therefore, a ceiling effect for the SDQ summary




Fig. 1 displays the distributions of change in score since
baseline of clinically stable and improved subjects for the
compared outcome measures. The median change in SDQ
score since baseline for clinically stable subjects is small,
while it is large for improved subjects. There is some over-
lap of the associated IQRs. For shoulder pain and chief
complaint there is no overlap of the IQRs around their me-
dians (Fig. 1). The non-parametric CRRs for the SDQ, the
chief complaint, and shoulder pain are 1.14, 1.59, and 1.96
respectively. Since the CRRs of symptoms (0.56) and mo-
bility (0.40) are smaller than 1, we consider these outcome
measures not responsive.
Fig. 3 displays the ROC curves for the compared out-
come measures. We consider them all responsive, since





















 0.67. Under the assumption of equal utility of true and
false positives, the SDQ discriminates well between im-
proved and stable subjects when 10% to 60% of the applica-
ble items change in score from yes to no. When 50% of the
applicable items change from yes to no, the SDQ has the
highest likelihood for correct discrimination between im-
proved and stable subjects. The chief complaint, shoulder
pain, and symptoms have the highest likelihood for correct
discrimination between improved and stable subjects when
VAS scores improve 70, 50, and 40 points of the maximum
of 100, whereas functional mobility has poor ability to dis-




We wanted to know whether patients with shoulder dis-
orders perceived change in their ability to perform func-
tional activities in daily life in a normal manner. For this
purpose we designed the SDQ, a 16-item measure for func-
tional status limitation in patients with shoulder disorders.
The selection of items was based on functional status limita-
tions most frequently reported to, and judged crucial in the
evaluation of treatment outcome by relevant health care
professionals. The SDQ focuses on how symptoms and
complaints of patients with shoulder disorders affect their
ability to perform daily activities. In our experience, the
SDQ is convenient for patients since it is easy to complete,
taking only a little time, while the chosen answer options
are easily quantifiable and interpretable, both on item level
and as a summary score. We only included subjects with lo-
cal shoulder disorders. For reasons of efficiency of the de-
sign of our clinical trial we excluded 84 subjects because of
their favorable prognosis at baseline and 2 for their poor
prognostic status at baseline. At the 6-week follow-up, the 2
subjects at the negative end of the prognostic spectrum re-
ported a deterioration of their complaints, while 58% of the
other 84 subjects reported very large improvement (includ-
ing complete recovery)—a recovery rate which was never
reached by the trial participants within 12 months. These
exclusions clearly resulted in lower estimates of responsive-
ness of the SDQ and the other instruments. Therefore, we
believe that the SDQ is a suitable instrument for assessing





There is no gold standard that provides a valid and reli-
able estimate for clinically relevant change in patients with
shoulder disorders. In the absence of such a gold standard,
its definition depends on the judgment by either clinician or
patient. We consider the patient’s self-report to be the best
estimate for clinically relevant change. Therefore, we de-
cided to use it as an external criterion in the analysis of re-
sponsiveness. Although this external criterion appears to
 




provide a clinically relevant difference, it does not necessar-
ily represent the minimal clinically relevant change. Never-
theless, the SDQ detected relatively small changes in scores
since baseline for clinically stable subjects and relatively
large changes for clinically improved subjects. The majority
of the 180 participants in our study improved, while very
few deteriorated. The identification of a ceiling effect in the
study population might be explained by the small number of
clinically deteriorated subjects. It is obvious that this popu-
lation cannot be used to demonstrate the ability of the SDQ
to pick up deterioration. Therefore, it cannot be concluded
from our study that the SDQ is more likely to pick up im-
provement than deterioration.
We consider the SDQ to be an outcome measure for the
Fig. 2. Bar chart for changes in answers between baseline and follow-up for 16 SDQ items in 180 subjects.
Fig. 3. Receiver operator characteristic (ROC) curves for stable subjects (n 5 82) and improved subjects (n 5 92) at multiple cut-off points for changes in
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severity of functional status limitation in patients with
shoulder disorders that is as responsive as any of the com-
pared outcome measures. The highest likelihood of accurate
discrimination between clinically stable and improved sub-
jects for the SDQ in this study is established when 50% of
the applicable items change in score from yes to no, while
the smallest improvement with the highest likelihood of ac-
curate discrimination between stable and improved subjects
proved to be a change in score from yes to no for 10% of the
applicable items.
Test-retest reliability of the SDQ appears to be sufficient;
that is, there is little variation in scores in patients who, ac-
cording to our external criterion, are considered to be clini-
cally stable. Our study, however, is not designed to demon-
strate the discriminative ability of the SDQ for high and low
functional status scores. For this, a study with a cross-sec-
tional design would be needed, with sufficient numbers of
subjects with high and low functional status scores that are
stable over time.
Differences in the nominator due to many NA responses
may have implications for the interpretation of SDQ scores
(e.g., affirming 10 out of 10 items may not reflect the same
functional status limitation as affirming 10 out of 16 items).
But it is not clear whether the number of NA responses is
related to the severity of the shoulder disorder, or whether a
reduction in the number of NA scores reflects improvement.
When, for a specific item, a NA response was given at base-
line, 6-week measurement, or both, it was impossible to cal-
culate change scores since baseline. An alternative approach
to including items with an NA response in the analysis, is to
replace NA responses by the previous or following re-
sponse, its opposite or both. This allows us to perform a
sensitivity analysis, in order to estimate the influence of NA
responses. In our study, very few NA responses were ob-
tained. A sensitivity analysis did not show major influence
of NA responses with respect to the CRR and AUC (data
not shown). We did not use a nominal or an ordinal re-
sponse scale to evaluate why or to what extent certain activ-
ities were not carried out. Now, since its applicability and
responsiveness is established, it would be worthwhile to see
how such changes in scaling might improve the perfor-




The relative ranking of the outcome measures according
to the CRR and AUC is quite similar. Thus, our results are
not the result of expressing responsiveness according to one
or the other method. The differences between instruments,
however, are more apparent with the CRR than with the
AUC. This fact is also reported in other responsiveness
studies [14,22,23]. One explanation for the differences in
responsiveness is the difference in recall period: 24 hours
for the SDQ versus 1 week for the other outcome measures.
The most likely explanation for the differences in respon-
siveness between the compared outcome measures, how-
ever, is the difference in the variance of the change in score
since baseline in clinically stable subjects. The differences
in these variances are likely to be determined by the nature
of the compared outcome measures. For example, the chief
complaint is an individually-tailored measure for functional
status limitation that includes only one activity of daily life.
In addition, the compared measures will show different re-
covery patterns. For example, shoulder pain is known to
subside rapidly over a short time in many patients, while




Almost simultaneously, three functional status measures
were developed that are similar to the SDQ. The Disability
Questionnaire by Croft et al. [8], includes 22 items with a
yes-no answer scale and a 24-hour recall frame. The items
of the Disability Questionnaire concern functional activities
and movements with the arm. The Shoulder Pain and Dis-
ability Index (SPADI), developed by Roach et al. [9], con-
sists of a separate 5-item pain scale and an 8-item disability
scale, with the preceding week as the recall frame. In order
to make the SPADI suitable for telephone administration,
the original visual analogue answer scales have been con-
verted into 0–10 numerical scales [24]. The Shoulder Rating
Questionnaire by l’Insalata et al. [10] consists of 19 items
with a 5-point ordinal answer scale: 4 relate to pain, 6 to
daily activities, 3 to recreational and athletic activities, 5 to
work, and 1 to satisfaction. The Shoulder Rating Question-
naire also includes a visual analogue scale for global assess-
ment, as well as an item to indicate the domain of most im-
portant improvement. The Shoulder Rating Questionnaire
has a recall frame of 1 month. As with the SDQ, these three
measures all include items that refer to problems with sleep-
ing, dressing, and functional activities and movements with
the arm. The overlap with respect to item content is largest
between the SDQ and Croft’s Disability Questionnaire. Van
der Windt et al. evaluated the responsiveness of the SDQ
during a survey of primary care in the Netherlands. She re-
ported AUCs of 0.84 and 0.90 at 3 and 6 months follow-up,
respectively [23]. The responsiveness of the SPADI was es-
tablished in primary care in the United States by Williams et
al. [24] and Heald et al. [25] Williams et al. reported an
AUC of 0.91 at 3-month follow-up [24] while Heald et al.
reported a standardized response mean of 1.38 [25]. For
their evaluation of responsiveness, Williams, Van der
Windt, and Heald also used patient report of improvement
as external criterion.
 
5.4. Epilogue and recommendations
 
The results reported in this paper are based on the Dutch
version of the SDQ in a population of patients with soft tis-
sue shoulder disorders in primary care physiotherapy. Al-
though they require confirmation by other investigators,
these results suggest that the SDQ is at least as responsive
as the compared outcome measures, and ready for use in
 




clinical trials. It is very likely, however, that the outcome of
the SDQ and the compared measures will be different in a
population in another health care setting or with another
cultural background and language. Therefore, a formal
translation [26] is indicated before using the preliminary
English translation of the SDQ (Appendix).
It would be worthwhile to evaluate the responsiveness of
the SDQ and its potential floor and ceiling effects in another
population and health care setting, relative to that of other
measures for functional status limitation of the shoulder.
Furthermore, because it has been shown to improve respon-
siveness of other disease-specific functional status question-
naires [27,28] reduction of the number of items (e.g., ex-
cluding items 7 and 16 because they yield hardly any
information), as well as the use of VAS or Likert scales,
should be given attention in future studies. Moreover, be-
fore the SDQ is used for cross-sectional discriminative pur-
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How to complete this questionnaire: The items of this questionnaire relate to your injured shoulder. If you have
trouble with both shoulders, please complete the questionnaire for only one shoulder, that is, the one that was
treated (or the side on which you write). When this shoulder hurts, you may experience problems performing
daily activities in a normal manner. This list contains 16 statements that shoulder disorder patients have used to
describe the situations in which they experience pain and what some of the effects may be. When you read the
statements, you may find that some stand out because they apply to your situation today (the past 24 hours). As
you go through the list, think of how you felt during the past 24 hours. For each entry, check for yourself whether
you performed the mentioned activity.
Examples NA Yes No




 lie on your 
shoulder during the past 24 hours, put a check mark under NA (not applicable).




. . . .
2. You did perform the activity during the past 24 hours, e.g., you opened or closed a 











3. You did perform the activity during the past 24 hours, e.g., you did lean on your elbow 




 while you were leaning 
on your elbow or hand, put a check mark under NO.




Shoulder Disability Questionnaire, 16 items
NA Yes No
For which shoulder do you complete this questionnaire?
Right/Left (circle one). . . . . . .
1. I wake up at night because of my shoulder. . . . . . .
2. My shoulder is hurts when I lie on it. . . . . . .
3. Because of my shoulder I have trouble putting on a coat or a sweater. . . . . . .
4. My shoulder hurts during my usual daily activities. . . . . . .
5. My shoulder hurts when I move my arm. . . . . . .
6. My shoulder hurts when I lean on my elbow or hand. . . . . . .
7. My shoulder hurts when I write or type. . . . . . .
8. My shoulder hurts when I hold my car steering wheel or my bike handlebars. . . . . . .
9. My shoulder hurts when I lift and carry something. . . . . . .
10. My shoulder hurts when I reach or grasp above shoulder level. . . . . . .
11. My shoulder hurts when I open or close a door. . . . . . .
12. My shoulder hurts when I bring my hand towards my buttocks. . . . . . .
13. My shoulder hurts when I bring my hand towards my lower back. . . . . . .
14. My shoulder hurts when I bring my hand towards the back of my head. . . . . . .
15. I rub my shoulder more than once during the day. . . . . . .
16. I am irritable and bad tempered with people because my shoulder hurts. . . . . . .
